Gerresheimer AG (GRRMF)
29.05
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Gerresheimer EPS Diluted (Quarterly) : -3.345 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2026 | -3.345 |
| November 30, 2025 | -10.34 |
| August 31, 2025 | -0.4269 |
| May 31, 2025 | 0.5473 |
| February 28, 2025 | -0.3867 |
| November 30, 2024 | 1.167 |
| August 31, 2024 | 0.8569 |
| May 31, 2024 | 1.015 |
| February 29, 2024 | 0.4092 |
| November 30, 2023 | 1.287 |
| August 31, 2023 | 0.887 |
| May 31, 2023 | 1.136 |
| February 28, 2023 | 0.4101 |
| November 30, 2022 | 1.045 |
| August 31, 2022 | 0.8958 |
| May 31, 2022 | 0.8654 |
| February 28, 2022 | 0.387 |
| November 30, 2021 | 1.009 |
| August 31, 2021 | 0.7237 |
| May 31, 2021 | 1.075 |
| February 28, 2021 | 0.3558 |
| November 30, 2020 | 1.128 |
| August 31, 2020 | 0.931 |
| May 31, 2020 | 1.010 |
| February 29, 2020 | 0.1455 |
| Date | Value |
|---|---|
| November 30, 2019 | -2.924 |
| August 31, 2019 | 0.6591 |
| May 31, 2019 | 1.666 |
| February 28, 2019 | 3.585 |
| November 30, 2018 | 1.579 |
| August 31, 2018 | 0.6826 |
| May 31, 2018 | 0.7272 |
| February 28, 2018 | 1.879 |
| November 30, 2017 | 1.416 |
| August 31, 2017 | 0.9448 |
| May 31, 2017 | 0.8444 |
| February 28, 2017 | 0.4349 |
| November 30, 2016 | 1.584 |
| August 31, 2016 | 1.106 |
| May 31, 2016 | 1.059 |
| February 29, 2016 | 0.5686 |
| November 30, 2015 | 1.924 |
| August 31, 2015 | 0.6446 |
| May 31, 2015 | 0.71 |
| February 28, 2015 | 0.4117 |
| November 30, 2014 | 0.7993 |
| August 31, 2014 | 0.782 |
| May 31, 2014 | 0.8412 |
| February 28, 2014 | 0.3962 |
| November 30, 2013 | 1.066 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evotec SE | -0.1526 |
| Lifecore Biomedical, Inc. | -0.1897 |
| Repligen Corp. | 0.0884 |
| Bio-Techne Corp. | 0.348 |
| Codexis, Inc. | -0.1318 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -126.36M |
| Revenue (Quarterly) | 558.10M |
| Total Expenses (Quarterly) | 684.60M |
| Enterprise Value | 3.440B |
| Gross Profit Margin (Quarterly) | 10.37% |
| Profit Margin (Quarterly) | -22.64% |
| Earnings Yield | -46.70% |
| Normalized Earnings Yield | -24.79 |